Photo via Toronto Star

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans

Read the original at Toronto Star ↗
Cite

Perrone, M. (2026, November 18). White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans. Toronto Star. https://www.thestar.com/news/world/united-states/white-house-pulls-fda-nominee-heidi-overton-after-wavering-support-from-senate-republicans/article_b5b4b993-98a9-598d-8a00-ccb4acd917b5.html

Dated from the outlet's own feed. Check the original for its byline.

Toronto Star · collected 2026-11-18 · by Matthew Perrone

Quick Summary

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented her from gaining the necessary votes for confirmation.
Written by AI on 2026-11-18, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

How they differ

11 outlets covered “White House withdraws Heidi Overton’s nomination to become”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Toronto StarThis outlet18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans (this article)
CBS News18 Nov

The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.

White House drops Heidi Overton's nomination for FDA commissioner →2 articles from CBS News on this story
New York Post18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback →
The Straits Times18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says →
NBC News18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…

White House drops Heidi Overton’s FDA nomination →
Show 5 more outlets
ABC News (US)18 Nov

Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.

Trump's pick Heidi Overton dropped as nominee for FDA commissioner →
Just the News18 Nov

The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report →
The Guardian18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…

White House withdraws nomination of Heidi Overton to lead FDA →
Daily Caller18 Nov

The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…

MAHA Rejoices After White House Drops Controversial FDA Nomination →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact8
The headlines (10)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says The Straits Times · attributed to a source

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report Just the News · attributed to a source

Trump FDA nominee Heidi Overton struggling to win GOP support CBS News · stated as fact

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback New York Post · stated as fact

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans Toronto Star · stated as fact

White House drops Heidi Overton’s FDA nomination NBC News · stated as fact

White House pulls Trump’s FDA pick Heidi Overton on eve of Senate panel vote Fox News · stated as fact

Trump's pick Heidi Overton dropped as nominee for FDA commissioner ABC News · stated as fact

White House withdraws nomination of Heidi Overton to lead FDA The Guardian · stated as fact

White House withdraws Heidi Overton’s nomination to become next FDA commissioner Washington Examiner · stated as fact

The full story: what happened, how it changed, and all 12 articles →

Compared with similar articles

This article reads leans right and hedges 0% of its claims. Each row says how that neighbour differs.
The Guardian
Leans right Hedges 1 of 18 claims Outlet record 64/100
Just The News
Hedges 2 of 10 claims Outlet record 59/100
NBC News
Leans right Hedges 1 of 19 claims Outlet record 78/100
CBS News
Hedges 1 of 4 claims Outlet record 67/100
New York Post
Leans left further left than this Hedges 0 of 7 claims Outlet record 66/100
The Straits Times
Hedges 3 of 17 claims Outlet record 64/100
Fox News
Hedges 0 of 1 claims Outlet record 67/100
Washington Examiner
Hedges 0 of 2 claims Outlet record 67/100
CBS News
Leans right Hedges 3 of 33 claims Outlet record 67/100
The Daily Caller
Hedges 4 of 27 claims Outlet record 93/100

Story

White House withdraws Heidi Overton’s nomination to become
Other · 12 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
3
sentences that state something as happening or true
Uncertain
0%
0 of 3 hedged ("reportedly", "may", "according to")
Leaning
Leans right
of the writing, not the subject · beta estimate
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
12
Other
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-18 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 15670 article(s) · 31 correction(s) detected
Running correction rate · 31 correction(s)
2026-11-17
Correction
2026-10-26
Correction
2026-10-24
Correction
2026-10-07
Correction
2026-09-24
Correction

Who wrote this

Matthew Perrone
9 article(s) here · 0 carrying a prediction
The effort on peptides, driven by Kennedy’s Department of Health and Human Services, faced overwhelming pushback among FDA drug staffers who warned it could undermine the agency’s longstanding mission of keeping unproven health products off the U.S. market, according to the people familiar with its development.
The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug’s use curtailed.
At a MAHA summit featuring AI and Silicon Valley executives, Kennedy declared that the technology would free Americans from “medical tyranny” by allowing them to “fact check their own medical advice.”
WASHINGTON (AP) — President Donald Trump’s nominee to take over the Food and Drug Administration is set to answer questions Thursday, with Senate lawmakers likely to focus on her plans for vaccines, the abortion pill and other products that have come under new scrutiny at the regulatory agency.
Your data may be shared with advertisers, social media companies and others Americans often assume that any personal health information they share is protected by HIPAA, the federal privacy law that governs the handling of medical information.
The new clinical guidance, released late Thursday, outlines how the program would work.
The new clinical guidance, released late Thursday, outlines how this program will function.
Also by Matthew Perrone
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 9 articles by Matthew Perrone →

Topics

FDA Senate The White House WASHINGTON the Food and Drug Administration

Subjects

Trump PERSON · 3× FDA ORG · 2× Heidi Overton PERSON · 1× Marty Makary PERSON · 1× Overton PERSON · 1× Senate ORG · 1× The White House ORG · 1× WASHINGTON GPE · 1× White House ORG · 1× the Food and Drug Administration ORG · 1×

Narrative

The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation.
framing: assertive · carried by 1 article(s) · first seen 2026-11-18

Claims (3 extracted, 0 hedged)

The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation. asserted
she → say → confirmation
Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for Trump or conservative groups aligned with his agenda. asserted
Overton → spend → agenda
Her nomination in August was seen as a move to bring a stabilizing Trump loyalist to the FDA after a tumultous year under Trump’s first FDA commissioner, Dr. Marty Makary. asserted
nomination → see → commissioner
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support